Osborne Clarke advises Cancer Rop on $10M investment into cancer vaccine firm, Oxford Vacmedix
International legal practice Osborne Clarke has advised South Korean biotech company, Cancer Rop Co. (formerly known as MG Med Inc.)...
Published on
14/03/2018
Read time
2m